Fig. 6From: Sex hormones influence survival of patients with metastatic urothelial carcinoma undergoing immune checkpoint therapyBaseline levels of sex hormones in female responders and non-responders. Boxes denote medians with interquartile ranges, whiskers span over 150% interquartile range. Female responders had a significantly higher LH/FHS ratio at baseline in therapy response, *p < 0.05. SD/PD (n = 6), CR/PR (n = 4)Back to article page